We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Your Password has changed! Please login again
Cart
Outdated Browser Detected
Our website has detected that you are using an outdated browser that will prevent you from accessing certain features.
Please use one of the below recommended browsers to improve your browsing experience
Today’s business environment demands a seamless and continual transition of digital experience to conduct business and engage various stakeholders in the same way we conduct the rest of our lives outside work. The experience expectation is consistent across devices of choice from phones to tablets to laptops. That’s why West partners with the world’s top pharmaceutical, biotech, device and diagnostic companies to embrace technology that supports the patients they serve with online resources and tools to better manage their health. In turn, we’re looking to support our customers with digital tools to help speed the research and development process of bringing life-saving medicines to patients that need them.
Companies seeking to bring an injectable medicine to market are required to complete an immense amount of research on the medicine itself, but they must also study the containment or device options to help ensure that medicine is delivered safely to the patient. The regulatory hurdles associated with combination therapies that include both the medicine, together with a device, represent a host of additional regulatory requirements.
To support customers, West’s Knowledge Center offers an online repository of scientific and regulatory support content that can help customers get the information they need quickly to manage this regulatory process. West also offers commonly requested, detailed product information, including specifications and drawings, on our entire portfolio of elastomer packaging components, pre-filled syringe solutions and wearable devices. Recently, we added the ability to purchase some of these same products through our online store. All of these services are available across a range of digital platforms, so that customers can easily access this information 24 hours a day, regardless of the device they use.
This is just one of the ways West is working to Simplify the Journey™ for our customers, by making it easier for our customers to do what we consider to be some of life’s most important work—developing innovative new medicines to address unmet medical needs. To learn more watch the above video or visit the West Knowledge center.
#SimplifytheJourney #WestByYourSide
Simplify the Journey™ is a trademark of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.
Andrea Straka, Senior Technical Account Specialist, will present “Sterilization Effects on Elastomer Characteristics and Functionality in Sterile Parenteral Drug Products” at the PDA Annual Meeting in San Antonia, Texas, April 7-9, 2014.
In view of patient safety and product quality, extractables and leachables assessments of pharmaceutical packaging and delivery systems have become an integral part of both development and regulatory submissions. Two crucial USP guidance chapters, USP <1663> “Assessment of Extractables Associated with Pharmaceutical Packaging/Delivery Systems” and USP <1664> “Assessment of Drug Product Leachables Associated with Pharmaceutical Packaging/Delivery Systems” have been published to guide pharmaceutical companies on the practical and technical considerations required for extractables and leachables assessment programs.
With the growth of gene and cell therapies, there is an increased need to characterize container closure systems (CCS) at the low temperatures experienced during their lifecycles: ultra-low (-80°C) for genes and cryogenic (-180°C) for cells. West’s Integrated Solutions platform includes the state-of-the-art container closure integrity (CCI) capabilities needed for these therapies.
The revision to the United States Pharmacopeia (USP) General Chapter <1> Injections, Labeling on Ferrules and Cap Overseals standard becomes official on December 1, 2013. The revision will limit printing to <span style="text-decoration: underline;">only</span> cautionary statements on the top surface of the ferrule or cap overseal of a vial containing an injectable drug product sold within the United States. Seals with the embossed “Flip-Off” or printed with other non-cautionary labeling will not be compliant with this new standard.